219673 Sigma-AldrichCFTR-F508del Corrector II, Corr-4a - CAS 421580-53-2 - Calbiochem
A cell-permeable bisaminomethylbithiazole compound that is reported to rescue/correct the folding defect of CFTR δF508 mutant via direct interaction.
More>> A cell-permeable bisaminomethylbithiazole compound that is reported to rescue/correct the folding defect of CFTR δF508 mutant via direct interaction. Less<<同義語: Cystic Fibrosis Transmembrane Conductor Regulator Mutant Corrector II, N-(2-(5-Chloro-2-methoxy-phenylamino)-4ʹ-methyl-[4,5ʹ]bithiazolyl-2ʹ-yl)-benzamide, Corr-4
お勧めの製品
概要
Replacement Information |
---|
主要スペック表
CAS # | Empirical Formula |
---|---|
421580-53-2 | C₂₁H₁₇ClN₄O₂S₂ |
価格&在庫状況
カタログ番号 | 在庫状況 | 包装 | Qty/Pk | 価格 | 数量 | |
---|---|---|---|---|---|---|
219673-10MGCN |
|
10 mg |
|
— |
Product Information | |
---|---|
CAS number | 421580-53-2 |
Form | Light beige solid |
Hill Formula | C₂₁H₁₇ClN₄O₂S₂ |
Chemical formula | C₂₁H₁₇ClN₄O₂S₂ |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Purity | ≥95% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
カタログ番号 | GTIN |
219673-10MGCN | 04055977200911 |
Documentation
CFTR-F508del Corrector II, Corr-4a - CAS 421580-53-2 - Calbiochem (M)SDS
タイトル |
---|
CFTR-F508del Corrector II, Corr-4a - CAS 421580-53-2 - Calbiochem 試験成績書(CoA)
タイトル | ロット番号 |
---|---|
219673 |
参考資料
参考資料の概要 |
---|
Pedemonte, N., et al. 2010. Am. J. Physiol. Cell Physiol. 298, C866. Young, A., et al. 2009. Biochem. J. 421, 377. Wang, Y., et al. 2007. J. Biol. Chem. 282, 33247. Wang, Y., et al. 2007. Mol. Pharmacol. 71, 751. Wang, Y., et al. 2007. Biochem. J. 406, 257. Pedemonte, N., et al. 2005. J. Clin. Invest. 115, 2564. |